Insider · CIK 0001500332
Sean Martin
Files at GENB (Generate Biomedicines, Inc.). First filing -, latest -.
In brief
Sean Martin files SEC Form 4 as officer at GENB (Generate Biomedicines, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sean Martin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +190,034 | $0.00 | $0 | 190,034 | Mar 2, 2026 |
Questions about Sean Martin
Answered from the filings on this page, as of the latest one.
Is Sean Martin buying or selling?
Sean Martin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sean Martin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sean Martin has 0.
Where does Sean Martin file Form 4?
Sean Martin has filed Form 4 at GENB (Generate Biomedicines, Inc.) as Chief Legal Officer & GC. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.